Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02145351 · ClinicalTrials.gov registry record · NA

Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure

A NA study of Heart Failure, Diastolic and Heart Failure With a Preserved Ejection Fraction, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT02145351 is a NA study of Heart Failure, Diastolic and Heart Failure With a Preserved Ejection Fraction that has completed, run by Mayo Clinic. The registered enrollment target is 32 participants, below the 318-participant average among 14 other Heart Failure, Diastolic trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02145351, a NA study of Heart Failure, Diastolic and Heart Failure With a Preserved Ejection Fraction, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

Determine the impact of restoring normal heart rate response during exercise and daily activity in patients with heart failure and a preserved ejection fraction (HFpEF) and chronotropic incompetence (CI).

Interventions

  • DEVICE Rate adaptive atrial pacing using a dual-chamber pacemaker
  • DEVICE Pacemaker system will be implanted but set to Pacing Off.

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2014-04-07
Est. Completion 2022-05-09
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT02145351

The ClinicalTrials.gov registry entry for NCT02145351 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 318-participant average among 14 other Heart Failure, Diastolic trials with a reported enrollment target (90% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Heart Failure, Diastolic appearing as the primary indexed condition, and to 2 interventions - of which Rate adaptive atrial pacing using a dual-chamber pacemaker is the first listed.

NCT02145351 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02145351 about?

NCT02145351 is a clinical study titled "Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure". Determine the impact of restoring normal heart rate response during exercise and daily activity in patients with heart failure and a preserved ejection fraction (HFpEF) and chronotropic incompetence (CI).

What is the current status of trial NCT02145351?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2014-04-07. Estimated completion is 2022-05-09.

What conditions does trial NCT02145351 study?

This clinical trial studies the following conditions: Heart Failure, Diastolic, Heart Failure With a Preserved Ejection Fraction, Chronotropic Incompetence.

What interventions are being tested in trial NCT02145351?

The interventions under investigation include: Rate adaptive atrial pacing using a dual-chamber pacemaker (DEVICE), Pacemaker system will be implanted but set to Pacing Off. (DEVICE).

Who is sponsoring clinical trial NCT02145351?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02145351 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure, Diastolic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.